IMMUNE-MEDIATED CYSTITIS

This adverse event was reported 115 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED CYSTITIS:

# Drug Count
0 NIVOLUMAB 51
1 PEMBROLIZUMAB 46
2 IPILIMUMAB 28
3 CARBOPLATIN 25
4 PACLITAXEL 19
5 PACLITAXEL (AIBUMIN-BOUND) 18
6 CAPECITABINE 8
7 OXALIPLATIN 8
8 PEMETREXED DISODIUM 8
9 PEMETREXED 6
See all common drugs associated with IMMUNE-MEDIATED CYSTITIS

IMMUNE-MEDIATED CYSTITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEFACLOR 1 0.0006
1 IPILIMUMAB 28 0.0006
2 RAMUCIRUMAB 4 0.0006
3 NIVOLUMAB 51 0.0005
4 AVELUMAB 2 0.0005
5 PEMBROLIZUMAB 46 0.0004
6 DOSTARLIMAB 1 0.0004
7 DECITABINE 1 0.0002
8 TREMELIMUMAB 1 0.0002
9 PEMETREXED DISODIUM 8 0.0002
See all drugs enriched for association with IMMUNE-MEDIATED CYSTITIS